Serum FSH bioactivity and inhibin levels in patients with gonadotropin secreting and nonfunctioning pituitary adenomas

1998 ◽  
Vol 21 (6) ◽  
pp. 372-379 ◽  
Author(s):  
S. Borgato ◽  
L. Persani ◽  
R. Romoli ◽  
D. Cortelazzi ◽  
A. Spada ◽  
...  
Keyword(s):  
Pituitary Adenomas ◽  
Nonfunctioning Pituitary Adenomas ◽  
Fsh Bioactivity

Pituitary apoplexy in clinically nonfunctioning pituitary adenomas: experience of a single center

2013 ◽  
Author(s):  
Apostolos Karagiannis ◽  
Dimitrios Boufas ◽  
Konstantinos Tzioras ◽  
Andreas Seretis ◽  
Andromachi Vryonidou
Keyword(s):  
Pituitary Adenomas ◽  
Pituitary Apoplexy ◽  
Single Center ◽  
Nonfunctioning Pituitary Adenomas

Gamma Knife Radiosurgery for Patients With Nonfunctioning Pituitary Adenomas: Results From a 15-Year Experience

2008 ◽  
Vol 70 (5) ◽  
pp. 1325-1329 ◽  
Author(s):  
Bruce E. Pollock ◽  
Joseph Cochran ◽  
Neena Natt ◽  
Paul D. Brown ◽  
Dana Erickson ◽  
...  
Keyword(s):  
Gamma Knife ◽  
Pituitary Adenomas ◽  
Gamma Knife Radiosurgery ◽  
Nonfunctioning Pituitary Adenomas

Endoscopic Endonasal Management of Nonfunctioning Pituitary Adenomas with Cavernous Sinus Invasion: Our Experience

2013 ◽  
Vol 149 (2_suppl) ◽  
pp. P48-P48
Author(s):  
Fabio Ferreli ◽  
Mario Turri-Zanoni ◽  
Stefania Gallo ◽  
Maurizio Bignami ◽  
Giustino Tomei ◽  
...  
Keyword(s):  
Cavernous Sinus ◽  
Pituitary Adenomas ◽  
Endoscopic Endonasal ◽  
Cavernous Sinus Invasion ◽  
Nonfunctioning Pituitary Adenomas

scholarly journals Tumor Recurrence or Regrowth in Adults With Nonfunctioning Pituitary Adenomas Using GH Replacement Therapy

2015 ◽  
Vol 100 (8) ◽  
pp. 3132-3139 ◽  
Author(s):  
N. C. van Varsseveld ◽  
C. C. van Bunderen ◽  
A. A. M. Franken ◽  
H. P. F. Koppeschaar ◽  
A. J. van der Lely ◽  
...  
Keyword(s):  
Replacement Therapy ◽  
Pituitary Adenomas ◽  
Tumor Recurrence ◽  
Nonfunctioning Pituitary Adenomas ◽  
Gh Replacement

scholarly journals Clomiphene fails to revert hypogonadism in most male patients with conventionally treated nonfunctioning pituitary adenomas

2011 ◽  
Vol 55 (4) ◽  
pp. 266-271 ◽  
Author(s):  
Rogerio Silicani Ribeiro ◽  
Julio Abucham
Keyword(s):  
Pituitary Adenomas ◽  
Erectile Function ◽  
Prospective Trial ◽  
Open Label ◽  
Dopaminergic Therapy ◽  
Testosterone Levels ◽  
Nonfunctioning Pituitary Adenomas ◽  
Before And After ◽  
Previously Treated ◽  
Male Patients

OBJETIVE: To evaluate the effect of clomiphene in men with hypogonadism and conventionally treated nonfunctioning pituitary adenomas (NFPA). PATIENTS AND METHODS: Open label, single-arm, prospective trial. Nine hypogonadal men (testosterone < 300 ng/dL and low/normal LH) with previously treated NFPA. Clomiphene (50 mg/day orally) for 12 weeks. Testosterone, estradiol, LH, FSH, prolactin and erectile function were evaluated before and after 10 days, 4, 8 and 12 weeks of clomiphene treatment. RESULTS: After clomiphene treatment, testosterone and erectile function improved in only one patient. In the remaining eight patients, testosterone levels decreased whereas LH, FSH, and estradiol remained unchanged. Insulin sensitivity increased in unresponsive patients. CONCLUSIONS: Compared with hypogonadal men with prolactinomas under dopaminergic therapy, clomiphene treatment failed to restore normal testosterone levels in most patients with conventionally treated NFPA.

Sign in / Sign up

Export Citation Format

Share Document